Literature DB >> 9231745

Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: demonstration of an additional 74-kDa component and age-related biochemical modifications.

N Sergeant1, J P David, M Goedert, R Jakes, P Vermersch, L Buée, D Lefranc, A Wattez, A Delacourte.   

Abstract

PHF-tau proteins are the major components of the paired helical filament (PHF) from Alzheimer's disease (AD) neurofibrillary lesions. They differ both qualitatively and quantitatively in their degree of phosphorylation when compared with native tau proteins. However, little is known about the extent and heterogeneity of phosphorylated sites or the isoform composition and the isoelectric variants of PHF-tau. Therefore, we have characterized PHF-tau proteins from cortical brain tissue homogenates of 13 AD patients using two-dimensional gel electrophoresis. Whatever the topographical origin of brain tissue homogenates, PHF-tau proteins shared the same two-dimensional gel electrophoresis profile made of a tau triplet of 55, 64, and 69 kDa. A 74-kDa hyperphosphorylated tau component was detected particularly in the youngest and most severely affected AD patients. This additional component of hyperphosphorylated tau was shown to correspond to the longest brain tau isoform. Furthermore, the isoelectric points of PHF-tau from older AD patients were significantly more basic, indicating a lower degree of phosphorylation. These results show that the severity of neurofibrillary degeneration of AD is modulated by age.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9231745     DOI: 10.1046/j.1471-4159.1997.69020834.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

Review 1.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.

Authors:  Katharina Schindowski; Alexis Bretteville; Karelle Leroy; Séverine Bégard; Jean-Pierre Brion; Malika Hamdane; Luc Buée
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

3.  Amyloid beta-mediated cell death of cultured hippocampal neurons reveals extensive Tau fragmentation without increased full-length tau phosphorylation.

Authors:  Jack Reifert; DeeAnn Hartung-Cranston; Stuart C Feinstein
Journal:  J Biol Chem       Date:  2011-04-11       Impact factor: 5.157

Review 4.  The biochemistry of Alzheimer's disease.

Authors:  G J Stege; G J Bosman
Journal:  Drugs Aging       Date:  1999-06       Impact factor: 3.923

Review 5.  Therapeutic strategies for tauopathies and drug repurposing as a potential approach.

Authors:  Majedul Islam; Fengyun Shen; Deepika Regmi; Deguo Du
Journal:  Biochem Pharmacol       Date:  2022-02-24       Impact factor: 6.100

6.  Long-term treatment of l-3-n-butylphthalide attenuated neurodegenerative changes in aged rats.

Authors:  Shiping Ma; Shaofeng Xu; Bin Liu; Jiang Li; Nan Feng; Ling Wang; Xiaoliang Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-02-12       Impact factor: 3.000

7.  Consensus brain-derived protein, extraction protocol for the study of human and murine brain proteome using both 2D-DIGE and mini 2DE immunoblotting.

Authors:  Francisco-Jose Fernandez-Gomez; Fanny Jumeau; Maxime Derisbourg; Sylvie Burnouf; Hélène Tran; Sabiha Eddarkaoui; Hélène Obriot; Virginie Dutoit-Lefevre; Vincent Deramecourt; Valérie Mitchell; Didier Lefranc; Malika Hamdane; David Blum; Luc Buée; Valérie Buée-Scherrer; Nicolas Sergeant
Journal:  J Vis Exp       Date:  2014-04-10       Impact factor: 1.355

8.  Cortical Alzheimer type pathology does not influence tau pathology in progressive supranuclear palsy.

Authors:  Kenichi Oshima; Dennis W Dickson
Journal:  Int J Clin Exp Pathol       Date:  2008-12-20

Review 9.  A walk through tau therapeutic strategies.

Authors:  Santosh Jadhav; Jesus Avila; Michael Schöll; Gabor G Kovacs; Enikö Kövari; Rostislav Skrabana; Lewis D Evans; Eva Kontsekova; Barbara Malawska; Rohan de Silva; Luc Buee; Norbert Zilka
Journal:  Acta Neuropathol Commun       Date:  2019-02-15       Impact factor: 7.801

Review 10.  Astroglia and Tau: New Perspectives.

Authors:  Gabor G Kovacs
Journal:  Front Aging Neurosci       Date:  2020-04-09       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.